Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

NCT00041353 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-07-11

No results posted yet for this study

Summary

RATIONALE: Examining biomarkers in fine-needle aspiration specimens from women at risk for breast cancer may improve the ability to detect breast cancer cells early and plan effective treatment.

PURPOSE: Screening trial to compare specific biomarkers based on fine-needle aspiration specimens from women at increased or normal risk of breast cancer.

Conditions

Interventions

OTHER

cytology specimen collection procedure

PROCEDURE

comparison of screening methods

PROCEDURE

study of high risk factors

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Fox Chase Cancer Center

    lead OTHER

Principal Investigators

  • Michael H. Torosian, MD · Fox Chase Cancer Center

Study Design

Purpose
SCREENING

Eligibility

Min Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2002-09-30
Completion
2002-09-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00041353 on ClinicalTrials.gov